Stephen Austin Klinge

Suggest Changes
Learn More
2512 Background: Recombinant human erythropoietin (EPO) has been a breakthrough in cancer- and renal insufficiency-associated anemia since 1988. Antibody-mediated PRCA is a rare, serious toxicity(More)